?VIROLOGY, IMMUNOLOGY & MICROBIOLOGY (VIM) CORE The broad, long-term objectives of the Virology, Immunology & Microbiology (VIM) Core are to provide laboratory support for HIV/AIDS-related basic and clinical HIV research to the UNC CFAR community.
The specific aims i nclude: (1) provide access to a diverse array of cost-effective services, (2) develop and evaluate new technologies applicable to research by CFAR investigators, (3) support of CFAR initiatives and collaborative research, (4) promote synergy between UNC CFAR Cores, UNC CFAR SWGs, and other CFARs, (5) provide mentoring, training, education, and outreach in the areas of virology, immunology, and microbiology, and (6) engage in evaluation and strategic planning. To achieve these aims, the VIM Core collaborates with UNC CFAR investigators to provide the services, specimens, equipment, or training needed by the investigators to achieve their research goals. The Core contributes to grant writing, design of experiments, and write-up of results. The services offered include specimen processing for clinical trials, provision of specimens from HIV-positive and HIV-negative individuals, viral quantitation, flow cytometry, measurement of antibodies and cytokines, and diagnostics for HIV and other sexually transmitted infections. New assays are developed in response to investigator requests and priority research areas for the CFAR. Management and strategic planning of the Core will be guided by consultation with the Core Directors, surveys of the CFAR membership, an Internal Advisory Board, an External Advisory Board, and through discussions at CFAR retreats.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI050410-22
Application #
9753884
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
22
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Costenbader, Elizabeth; Mangone, Emily; Mueller, Monique et al. (2018) Rapid organizational network analysis to assess coordination of services for HIV testing clients: an exploratory study. J HIV AIDS Soc Serv 17:16-31
Zule, William A; Latypov, Alisher; Otiashvili, David et al. (2018) Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles. Harm Reduct J 15:44
Molloy, Síle F; Kanyama, Cecilia; Heyderman, Robert S et al. (2018) Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. N Engl J Med 378:1004-1017
Hong, Jin-Liern; Jonsson Funk, Michele; LoCasale, Robert et al. (2018) Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population. Am J Epidemiol 187:817-827
Ong, Jason J; Fu, Hongyun; Smith, M Kumi et al. (2018) Expanding syphilis testing: a scoping review of syphilis testing interventions among key populations. Expert Rev Anti Infect Ther 16:423-432
Rosenberg, Nora E; Graybill, Lauren A; Wesevich, Austin et al. (2018) Individual, Partner, and Couple Predictors of HIV Infection among Pregnant Women in Malawi: A Case-Control Study. AIDS Behav 22:1775-1786
Golin, C E; Barkley, B G; Biddell, C et al. (2018) Great Expectations: HIV Risk Behaviors and Misperceptions of Low HIV Risk among Incarcerated Men. AIDS Behav 22:1835-1848
Srinivas, Nithya; Maffuid, Kaitlyn; Kashuba, Angela D M (2018) Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System. Clin Pharmacokinet 57:1059-1074
Montgomery, Nathan D; Tomoka, Tamiwe; Krysiak, Robert et al. (2018) Practical Successes in Telepathology Experiences in Africa. Clin Lab Med 38:141-150

Showing the most recent 10 out of 1688 publications